618 filings
Page 9 of 31
8-K
sp6x txv4c2zlij3
18 Nov 20
VBI Vaccines Announces Positive Interim Phase 1b/2a Data for Hepatitis B
8:55am
8-K
zdeamc4er1mmik
13 Nov 20
VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at The Liver Meeting® 2020
8:52am
8-K
1ckaddv1fqgk8yi4m8u
9 Nov 20
VBI Vaccines Announces e-Poster Presentation at the Society for Neuro-Oncology (SNO) 2020 Virtual Meeting
9:12am
8-K
y2q0 fd6nz
2 Nov 20
VBI Vaccines Announces Third Quarter 2020 Financial Results and Provides Corporate Update
11:31am
8-K
e98k 5b9qy83
26 Oct 20
Regulation FD Disclosure
9:34am
8-K
7w7ignusmsa9
15 Oct 20
VBI Vaccines to Present at the H.C. Wainwright Hepatitis B Virus (HBV) Mini-Conference
10:08am
8-K
ilweui86oig
9 Oct 20
VBI Vaccines Announces e-Poster Presentation at The Liver Meeting® 2020
10:00am
8-K
5a5r h080i
24 Sep 20
VBI Vaccines to Present at Upcoming Scientific Conferences
8:00am
8-K
9mcf sqaihj60updu
21 Sep 20
Entry into a Material Definitive Agreement
8:00am
8-K
errip89 esdfz
17 Sep 20
Regulation FD Disclosure
2:50pm
8-K
09w3e17
14 Sep 20
VBI Vaccines to Present Additional Biomarker Data from VBI-1901 Phase 1/2a Study in Recurrent GBM in an E-Poster at ESMO Virtual Congress 2020
9:27am
8-K
0l589d
31 Aug 20
VBI Vaccines Presents Phase 3 Sci-B-Vac® Data at EASL 2020
8:44am
8-K
dpnvw rq16m6
26 Aug 20
VBI Vaccines Announces Preclinical Coronavirus Program Data and Selection of Clinical Candidates with Potential as One-Dose Vaccines
8:30am
8-K
lcnm8ztj8g1vy 2kz3w
21 Aug 20
VBI Vaccines Announces Multiple Phase 3 Sci-B-Vac® Abstracts Accepted for Oral and Poster Presentations at EASL 2020
11:13am
8-K
s2z35p2zh x8ar
5 Aug 20
VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development
9:00am
8-K
pp5m7madzom
3 Aug 20
VBI Vaccines Announces Second Quarter 2020 Financial Results and Provides Corporate Update
9:10am
S-8
wkhjizjj
31 Jul 20
Registration of securities for employees
5:03pm
S-3ASR
bjndx8gksc9zc5z
31 Jul 20
Automatic shelf registration
4:58pm